These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7904940)
1. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation. Aliot E; Sadoul N; De Chillou C Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease. Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065 [TBL] [Abstract][Full Text] [Related]
3. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents. Nademanee K; Singh BN Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias. Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757 [TBL] [Abstract][Full Text] [Related]
6. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Lazzara R Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326 [TBL] [Abstract][Full Text] [Related]
7. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007 [TBL] [Abstract][Full Text] [Related]
8. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias. Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204 [TBL] [Abstract][Full Text] [Related]
9. Class III antiarrhythmic drugs. Singh BN; Ahmed R Curr Opin Cardiol; 1994 Jan; 9(1):12-22. PubMed ID: 8199363 [TBL] [Abstract][Full Text] [Related]
10. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias. Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Advani SV; Singh BN Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009 [TBL] [Abstract][Full Text] [Related]
12. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation. Campbell RW; Furniss SS Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732 [TBL] [Abstract][Full Text] [Related]
13. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction. Kassotis J; Sauberman RB; Cabo C; Wit AL; Coromilas J J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141 [TBL] [Abstract][Full Text] [Related]
14. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. Antz M; Cappato R; Kuck KH J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226 [TBL] [Abstract][Full Text] [Related]
15. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol]. Wehr M Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811 [TBL] [Abstract][Full Text] [Related]
17. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias]. Trappe HJ; Klein H; Lichtlen PR Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165 [TBL] [Abstract][Full Text] [Related]
18. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram. Steinbeck G; Bach P; Haberl R J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368 [TBL] [Abstract][Full Text] [Related]
20. Potential proarrhythmic effect of biventricular pacing: fact or myth? Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]